Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
National Resh Corp (NRC) delivers actionable healthcare experience insights through advanced analytics and proprietary methodologies. This news hub provides investors and industry professionals with essential updates on strategic initiatives shaping patient care innovation.
Access real-time press releases covering earnings disclosures, partnership announcements, and operational developments. Our curated feed simplifies tracking NRC's progress in transforming healthcare interactions through data-driven solutions.
Discover updates on key focus areas including patient engagement metrics, employee experience enhancements, and analytics platform innovations. Content is organized chronologically for efficient monitoring of NRC's market position and industry leadership.
Bookmark this page for streamlined access to verified NRC developments. Combine our updates with Stock Titan's financial tools to analyze the company's performance in healthcare experience optimization.
Cooper University Health Care has chosen NRC Health as its new partner for enhancing patient experience across its network. Cooper, serving over 2 million patients annually in Southern New Jersey and Delaware Valley, will utilize NRC Health's comprehensive platform and AI-powered solutions to gain patient insights and deliver human-centered care. The partnership aims to support Cooper's mission of serving, healing, and educating through data-driven insights and humanized healthcare solutions.
National Research (NRC Health) reported its Q3 2024 financial results, showing revenue of $35.8 million, down from $37.9 million in Q3 2023. Earnings per diluted share decreased to $0.24 from $0.32 year-over-year. The company's net indebtedness stood at $50.2 million, with total recurring contract value of $131.6 million. During the quarter, NRC returned $11.5 million to stockholders through dividends ($2.9 million) and stock repurchases ($8.6 million), buying back approximately 395,000 shares. The Board declared a quarterly dividend of $0.12 per share, payable January 10, 2025.
NRC Health, a leader in healthcare experience solutions, unveiled a suite of AI-enabled products at its 30th annual conference, HUB24. The new offerings, powered by the company's secure AI engine Huey, aim to enhance human connections in healthcare. Key announcements include:
1. New AI-powered products: nGage, nQuire, nVolve, nLighten, and nAct, designed to improve patient and employee experiences.
2. Acquisition of Nobl, a leader in advanced rounding solutions for healthcare organizations.
3. Partnership with Medallia to address issues impacting consumer and employee healthcare experiences.
These initiatives reinforce NRC Health's commitment to Human Understanding in healthcare, providing insights to improve patient care and organizational efficiency.
National Research (NRC Health) announced its Q2 2024 results and corporate developments. Revenue decreased to $35 million from $36 million in Q2 2023, while earnings per diluted share dropped to $0.26 from $0.29. The company's net indebtedness stood at $42 million, with a total recurring contract value (TRCV) of $138 million as of June 30, 2024.
NRC Health amended its credit agreement, extending the revolving loan facility maturity to May 28, 2027, and modifying term loan conditions. The company has 1.1 million shares remaining in its stock repurchase plan and declared a quarterly cash dividend of $0.12 per share. Additionally, NRC Health acquired NOBL Health for approximately $6 million, adding $2 million in TRCV. The company is also releasing new consumer and employee experience capabilities, as well as a proprietary AI engine.
National Research , dba NRC Health, (NASDAQ:NRC) announced first quarter 2024 results showing strong growth potential. The CEO highlighted the company's competitive edge in healthcare insights and innovative products. Financially, significant investments were made in technology and teams to support new product launches. The company returned $18 million to stockholders and focused on product innovation and growth investments.
FAQ
What is the current stock price of National Resh (NRC)?
What is the market cap of National Resh (NRC)?
